Head-to-head · Value Score
CoreAge Rx vs No BS RX
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, No BS RX a 85. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameNo BS RX
#24 · Grade A- · Great Deal
Est. first month
$179 (semaglutide), month to month
Save ~87% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 85 — an est. $99/mo first month, with no teaser step-up baked in. No BS RX isn't out of it: Anyone who wants to compare every term and every dose level without starting an intake to see a price.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | No BS RX |
|---|---|---|
| Value Score | 93 (A+) | 85 (A-) |
| Est. first month | $99/mo | $179 (semaglutide), month to month |
| Save vs brand-name | ~89% | ~87% |
| Semaglutide | $99/mo | $179/mo month-to-month (a separate low-dose program is $140) |
| Tirzepatide | $149/mo | $249/mo month-to-month (a separate low-dose program is $140) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
No BS RX
Twenty-four prices on one public page, four dispensing pharmacies named with addresses, and a no-intro-rate promise that survives the arithmetic.
Why it's a deal
- Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
- Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
- Six programs across four terms are published with no intake and no account
- A separately priced sleep program sits on the same page, including a diagnostic ring study at $33/mo
The fine print
- The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
- The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
- The Terms name four pharmacies and no operating company
- State availability is not published, and there is no brand-name lane
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to No BS RX.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.